Retrospective longitudinal study of patients and prescriber characteristics associated with new DOAC prescriptions in a CCG without restrictions to DOAC use

Description

Yes / Direct oral anticoagulants (DOACs) uptake for stroke prevention in atrial fibrillation has been slow.[1] This study aimed to profile the prescribing of DOACs over three years to identify factors associated with DOAC prescribing in a Clinical Commissioning Group (CCG) without restrictions to DOACs use. The objectives were to identify:
- Characteristics of patients prescribed oral anticoagulant (OAC) in a sample of general practices;
- Who initiated the prescribing of OAC;
- Recorded reasons for prescribing a DOAC rather than warfarin;

Links & Downloads

1. Medlinskiene K, Fay M and Petty D (2018) Retrospective longitudinal study of patients and prescriber characteristics associated with new DOAC prescriptions in a CCG without restrictions to DOAC use. International Journal of Pharmacy Practice. 26 (Suppl.1): 26-27.
2. http://hdl.handle.net/10454/16144
3. https://doi.org/10.1111/ijpp.12442

Tags

Direct oral anticoagulants (DOACs)

Warfarin

Prescriptions

Patient characteristics

Prescriber characteristics

Clinical Commissioning Group (CCG)

Additional Fields

Identifer	oai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/16144
Date	January 2018
Creators	Medlinskiene, Kristina, Fay, M., Petty, Duncan R.
Source Sets	Bradford Scholars
Language	English
Detected Language	English
Type	Abstract, Accepted manuscript
Rights	© 2018 Wiley. This is the peer reviewed version of the conference abstract above, which has been published in final form at https://doi.org/10.1111/ijpp.12442. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving., Unspecified